期刊文献+

瘦素与高血压动脉粥样硬化关系的研究进展 被引量:4

下载PDF
导出
摘要 瘦素是肥胖基因编码的一种具有内分泌功能的蛋白质产物,通过作用于瘦素受体而发挥一系列生物学效应。近年来大量研究显示瘦素与肥胖、高血压、糖尿病、动脉粥样硬化、脑卒中等疾病密切相关,其机制可能与加剧脂代谢紊乱、诱导氧化应激、增加交感神经活性、调节血管张力、促进内皮细胞炎性反应、诱导血管平滑肌细胞增殖迁移、增加泡沫细胞形成、促进血小板聚集及血栓形成等多种机制有关。本文对瘦素与高血压、动脉粥样硬化关系的研究进展进行了综述。
出处 《西南军医》 2012年第1期97-99,共3页 Journal of Military Surgeon in Southwest China
  • 相关文献

参考文献23

  • 1Savoia C Sehiffrin EL.Inflammation in hypertension[J].Curr OPin NePhrol Hypertens,2006,15(2):152-8.
  • 2Chicurel M.Whatever happened to leptin[J].Nature,2000,404:538-540.
  • 3Beltowski J.Leptin and the regulation of endothelial function in physi-ological andpathological conditions[J].Clin Exp Pharmacol Physiol.2011Oct4.doi:10.1111/j.1440-1681.
  • 4Barba G.Plasma Leptin and Blood Pressure in Men:Graded Associa-tion Independent of Body Mass and Fat Pattern[J].Obes Res,2003,11:160-166.
  • 5Beltowski J.Role ofl ePtin in blood Pressure regulation and arterial hyPertension[J].J Hypertension,2006,24(5):789-801.
  • 6Correia ML.Rahmouni K.Role of leptin in the cardiovascular and en-docrine complications of metabolic syndrome[J].Diabetes Obes Metab,2006,8(6):603-610.
  • 7D maso AR,de Piano A,Sanches PL,et al.Hyperleptinemia in obese adolescents deregulates neuropeptides during weight loss[J].Peptides.2011Jul;32(7):1384-91.Epub2011May6.
  • 8Tu W,Eckert GJ,Dimeglio LA,et al.Intensified Effect of Adiposity on Blood Pressure in Overweight and Obese Children[J].Hypertension.2011Oct3.
  • 9Haynes WG.Role of leptin in obesity-related hypertension[J].Exp Physiol,2005.90:683-688.
  • 10Surmi B K,Atkinson R D,Gruen M L,Coenen KR,Hasty AH.The role of macrophage leptin receptor in aortic root lesion formation[J].Am J Physiol Endocrinol Metah,2008,294:E488-E495.

同被引文献93

  • 1王岳屏,严颂琴,彭国顺,谌剑飞.高血压病病人不同证候与糖脂肪代谢及瘦素水平的关系[J].中西医结合心脑血管病杂志,2007,5(6):476-478. 被引量:4
  • 2Northcott JM,Yeganeh A, Taylor CG, et al. Adipokines and the cardiovascular system : mechanisms mediating health and disease. Can J Physiol Pharmacol, 2012, 90 : 1029-1059.
  • 3Mathew B, Patel SB, Reams GP, et al. Obesity-hypertension: emerging concepts in pathophysiology and treatment. Am J Med Sci, 2007, 334: 23-30.
  • 4Correia ML, Haynes WG. Lessons from Leptin' s molecular biology: potential therapeutic actions of recombinant leptin and leptin-related compounds. Mini Rev Med Chem, 2007, 7: 31- 38.
  • 5Mancour LV,Daghestani HN, Dutta S, et al. Ligand-induced architecture of the leptin receptor signaling complex. Mol Cell, 2012, 48 : 6554561.
  • 6Munzberg Myers MG Jr. Molecular and anatomical determinants of central leptin resistance. Nat Neurosci, 2005, 8: 566-570.
  • 7Wauman J, Tavernier J. Leptin receptor signaling: pathways to leptin resistance. Front Biosci, 2011, 16 : 2771-2793.
  • 8Arias-Alvarez M, Garcia-Garcia RM, Torres-Rovira L, et al. Influence of leptin on in vitro maturation and steroidogenic secretion of cumulus-oocyte complexes through JAK2/STAT3 and MEK 1/2 pathways in the rabbit model. Reproduction, 2010, 139 : 523-532.
  • 9Jorgensen SB,O'Neill HM, Sylow L, et al. Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity. Diabetes, 2013, 62: 56-64.
  • 10Warne JP, Alemi F, Reed AS, et al. Impairment of central leptin-mediated PI3K signaling manifested as hepatic steatosis independent of hyperphagia and obesity. Cell Metab, 2011, 14: 791-803.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部